Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology-Molecular docking-Key target validation".
<h4>Objective</h4>To explore the potential mechanism of Shenkang injection (SKI) in the treatment of chronic renal failure based on network pharmacology and molecular docking technology, and to verify the core targets and key pathways by using the renal failure model.<h4>Methods<...
Main Authors: | Lin Zhou, Xiaohui Wang, Zhi Sun, Xiaoyue Bao, Lianping Xue, Zhanmei Xu, Pengfei Dong, Jinlan Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0291621&type=printable |
Similar Items
-
Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology—Molecular docking—Key target validation"
by: Lin Zhou, et al.
Published: (2023-01-01) -
Shenkang injection combined with alprostadil for chronic renal failure: A systematic review and meta-analysis
by: Feng Xie, et al.
Published: (2023-04-01) -
Shenkang protects renal function in diabetic rats by preserving nephrin expression
by: Zhihui Qu, et al.
Published: (2023-07-01) -
Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
by: Liang-Pu Luo, et al.
Published: (2021-12-01) -
Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway
by: Yan-Ni Wang, et al.
Published: (2022-08-01)